Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas

Published:2016-06-09 Issue:9 Volume:192 Page:649-657
ISSN:0179-7158
Container-title:Strahlentherapie und Onkologie
language:en
Short-container-title:Strahlenther Onkol

Author:

Lee Sung Uk,Moon Sung Ho,Cho Kwan Ho,Pyo Hong Ryull,Kim Joo Young,Kim Dae Yong,Kim Tae Hyun,Suh Yang-Gun,Kim Yeon-Joo

Funder

National Cancer Center

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Radiology Nuclear Medicine and imaging

Link

http://link.springer.com/content/pdf/10.1007/s00066-016-0985-9.pdf

Reference40 articles.

1. Ferlay J, Shin HR, Bray F et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917

2. Mountain CF (1997) Revisions in the international system for staging lung cancer. Chest J 111(6):1710–1717

3. Qiao X, Tullgren O, Lax I et al (2003) The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 41(1):1–11

4. Nyman J, Johansson K‑A, Hultén U (2006) Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer – mature results for medically inoperable patients. Lung Cancer 51(1):97–103

5. Soldà F, Lodge M, Ashley S et al (2013) Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort. Radiother Oncol 109(1):1–7

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypofractionated proton therapy for non-small cell lung cancer: Ready for prime time? A systematic review and meta-analysis;Cancer Treatment Reviews;2022-11

2. Proton Beam Therapy versus Photon Radiotherapy for Stage I Non-Small Cell Lung Cancer;Cancers;2022-07-26

3. The Role of Hypofractionation in Proton Therapy;Cancers;2022-05-02

4. Toxicity of Proton Therapy versus Photon Therapy on Salvage Re-Irradiation for Non-Small Cell Lung Cancer;Life;2022-02-16

5. Hypofractionated Proton Therapy for Non-Small Cell Lung Cancer: Ready for Prime Time? A Systematic Review and Meta-Analysis;SSRN Electronic Journal;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3